“a clear trend”

In addition, this difference regarding M30 levels and 30 days mortality was significant also in the subgroup of sepsis patients ( p = 0.007), while the smaller subgroup of nonsepsis patients showed a clear trend towards higher M30 levels in patients that died within 30 days after ICU admission ( p = 0.066). 4.

A clear trend toward lower blood product consumption was shown for the mini-AVR group (0 [0-520] vs 270 [0-750] mL, P = 0.066).

Although at present, the only statistically significant differences were obtained between adult patients with PCD patients and healthy children, a clear trend towards reduced NET formation can be noted ( p = 0.066). 2.7.

2 ), which was significant ( p = 0.04) In the entire cohort the decrease in ATP, although showing a clear trend, did not reach statistical significance ( p = 0.066), whereas ICD shocks did decrease significantly ( p = 0.028).

There was a clear trend towards an increased outgrowth when supplementing NGF with BDNF and NT-3 (3x cocktail) although it did not quite reach statistical significance ( p = 0.066).

Figure 4 demonstrates that compared to the DM group, there was a clear trend towards the inhibition of the expression and phosphorylation of AMPKα in the MICT group ( P =0.066, P =0.056).

However, in the DC, Cereboost® supplementation resulted in enhanced Lactobacillus levels, with a clear trend in the mucosal environment ( p = 0.066).

Despite this, a clear trend in mtCN change could be observed, particularly in the dose-dependent AAVMYO experiment, where the trend of mtCN is negatively correlated with dose, with the highest dose nearing significance ( p = 0.067) (Fig. 7D ).

Summary data illustrated that the lower dosage of cANF (0.07 mg/kg/day) did not prevent Ang II-mediated changes in HR (p = 0.915) ( Figure 5B ); however, there was a clear trend toward a reduction in cSNRT (p = 0.067) ( Figure 5C ) compared with Ang II alone.

There was no significant difference in duration of antibiotic use and use of non-invasive ventilation between the two groups, but there was a clear trend to a higher proportion of invasive ventilation in the eosinopenia group (34.1% vs 11.1%, p =0.067).

In contrast, to PCAs and RCCs, the co-expression of FBP1 and FBP3 failed statistical significance but showed a clear trend with 53 tumors that had high levels of FBP1 and FBP3 (p = 0.067).

Interestingly, SOX2 expression was significantly higher in patients without lymph node metastasis as compared to their N+ counterparts (p = 0.047), and a clear trend of higher SOX2 expression in patients with a lower tumor stage (p = 0.067) was observed.

Although no significant difference was noted, a clear trend for surgery was indicated ( p =0.067).

However, there was a clear trend ( p = 0.067) toward increased velocity in the H2 condition.

Interestingly, while we observed no difference between He and Ob myocytes, there was a clear trend towards an increased activation of STAT3 in DM myocytes compared to He myocytes (P = 0.067) and compared to Ob myocytes (P = 0.056) ( Figure 2B ).

The differences between the lesion locations did not reach statistical significance, but a clear trend ( p = 0.067), with detection rates of 11.4% vs. 12.5% vs. 42.9% in the peripheral, transition/central zone, and anterior fibromuscular stroma zones, respectively.

Moreover, the pair-wise comparison (Mann-Whitney U test) showed significantly higher levels in pre-DAAs HIV/HCV compared to the HIV group for IL-18 ( p = 0.008), IP-10 ( p < 0.0001) and VCAM-1 ( p < 0.0001) with a clear trend for ICAM-1 ( p = 0.067).

Although the long-term survival rates suggest a clear trend, with a 3-year survival rate of 12.5 % in the CK7+ group and 75 % in the CK7− group ( p -value = 0.067), the difference is not statistically significant.

Although not quite reaching significance, there was a clear trend toward patients in higher STTGMA quartiles having a 1.9x increase in impairment in both need for assistive device and decreased ambulatory capacity (p = 0.067).

There was also a clear trend supporting an inverse correlation between the size of the latent reservoir (log 10 IUPM) and time on treatment (n = 16, Spearman r = −0.4676, p = 0.0678) and virological suppression <50 copies/ml (n = 12, Spearman r = −0.3193, p = 0.3117).

A comparison of Kaplan–Meier survival curves showed a clear trend ( p = 0.0678) for a lower mortality rate in AAV8-A-I TAC mice compared to control TAC mice (hazard ratio for mortality of 0.543; 95% confidence interval (CI): 0.282 to 1.05) during eight weeks of follow-up ( Figure 1 ).

Although not reaching statistical levels by 2-way ANOVA (interaction p = 0.10) a clear trend for reduced T3/T4 levels was found in HFS ad lib group compared to NC controls ( p = 0.068) and to HFS TRF ( p = 0.055), comforting the idea of local hypothyroidism ( Figure 6 B).

27 In our study, HBEA was not associated with higher AF detection in the second Holter‐ECG compared with those with NSR, although a clear trend was observed at the 12‐month follow‐up (26% versus 13%, P =0.068).

At the same time, there was a clear trend for all mutated tumor samples collectively to show a colder phenotype compared to EGFR/ERBB2wt group ( P = 0.068), the majority of which could be assigned to the immunological group of ‘hot’ tumors (17/26 = 65% versus 9/26 = 35%).

Interestingly, there was a clear trend suggesting that patients with T-ALL harboring a BCL11B mutation had a higher percentage of CR ( P = .068) and negative MRD ( P = .050), although the data were not yet statistically significant at this point ( Figure 1B ).